[Form 4] Moelis & Co Insider Trading Activity
Nick Riehl, an officer and director at Moelis & Co (MC), reported receipt of restricted stock units (RSUs) on 09/18/2025. The Form 4 shows three grants labelled as 2023 Long Term Incentive RSUs, 2024 Incentive RSUs, and 2024 Long Term Incentive RSUs issued as dividend equivalents and recorded as acquisitions on that date. Each RSU represents the right to receive either a share of Class A common stock or cash equal to the share value upon settlement. The filing records beneficial ownership amounts of 979.01, 246.42, and 327.88 shares respectively after the transactions, with a reported price of $0 because these are dividend-equivalent RSUs that vest with the underlying awards.
- Alignment with shareholders: RSUs increase executive equity exposure and tie compensation to long-term company performance
- No cash outlay: Dividend-equivalent RSUs were issued at $0, reflecting crediting of value rather than payable consideration
- Potential dilution: Additional RSUs increase the pool of outstanding share equivalents which could dilute existing shareholders if settled in stock
Insights
TL;DR: Officer received dividend-equivalent RSUs that increase his vested equity exposure without an outlay of cash.
The Form 4 documents that Nick Riehl acquired RSUs on 09/18/2025 as dividend equivalents tied to prior incentive awards. These units are recorded at a $0 price because they represent additional award credits rather than market purchases. The resulting beneficial ownership figures—979.01, 246.42 and 327.88—increase his equity stake and further align management pay with shareholder performance. This is a routine compensation-related record rather than an open-market trade; it signals ongoing retention and incentive structuring but does not provide information on sale or hedging activity.
TL;DR: Dividend-equivalent RSUs reflect standard long-term incentive mechanics and vest with underlying grants, reinforcing retention incentives.
The filing clarifies these RSUs are dividend equivalents that will vest concurrently with the underlying incentive awards, which is consistent with common governance practice to preserve the economic value of deferred equity. There is no indication of altered vesting terms or special disposal. The reported attorney-in-fact signature indicates the filing was executed on behalf of the reporting person, a normal administrative practice. No governance red flags or unusual compensation structures are evident from this Form 4 alone.